Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

low-grade neuroendocrine tumor of the corpus uteri - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

low-grade neuroendocrine tumor of the corpus uteri

MONDO:0016270

Also known as:low-grade neuroendocrine tumor of the uterine corpuslow-grade neuroendocrine tumour of the uterine corpuswell-differentiated neuroendocrine neoplasm of the endometrium

Overview

Low-grade neuroendocrine tumor of the corpus uteri is an extremely rare uterine cancer typically characterized by a well demarcated, solid, frequently pedunculated tumor originating from neuroendocrine cells scattered within the endometrium, often associated with ectopic hormone production. Patients usually present with vaginal bleeding or discharge and a pelvic mass with a polypoid tumor sometimes protruding through the cervical canal. Symptoms related to ectopic hormone production (flushing, sweating, diarrhea, bronchospasm) may also develop.

ResearchLimited published research (8 articles)

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for low-grade neuroendocrine tumor of the corpus uteri.

8 publications have been identified in PubMed for low-grade neuroendocrine tumor of the corpus uteri. Research spans Case Report / Case Series (63%), Review / Meta-Analysis (25%), and Other (13%).

Recent Publications

Satala CB (2026). [PMID: 42196939](https://pubmed.ncbi.nlm.nih.gov/42196939/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Bode-Lesniewska B (2025). [PMID: 41073540](https://pubmed.ncbi.nlm.nih.gov/41073540/). *Virchows Arch*. [Case Report / Case Series]
Rikitake R (2025). [PMID: 40376725](https://pubmed.ncbi.nlm.nih.gov/40376725/). *Pathol Int*. [Review / Meta-Analysis]
Faridzi AS (2025). [PMID: 39819883](https://pubmed.ncbi.nlm.nih.gov/39819883/). *Am J Case Rep*. [Case Report / Case Series]
Yamamoto K (2025). [PMID: 40176851](https://pubmed.ncbi.nlm.nih.gov/40176851/). *Gynecol Oncol Rep*. [Case Report / Case Series]

Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 4:54 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:213736

GARD

Genetic and Rare Diseases Info Center

GARD:20483

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

low-grade neuroendocrine tumor of the corpus uteri

Overview

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team